Clinical trial
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
NCT01915277 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
- Lead sponsor
- Carelon Research
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 2, 2014
- Completion date
- October 17, 2017
- Enrollment
- 119 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
tetralogy of fallot, transposition of the great arteries, ventricular septal defect